A Randomized Controlled Trial to Compare the Glycemic Control, With or Without the Connected Solution, of Adult Type 2 Diabetic Participants on Basal Insulin in Taiwan

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 17, 2023

Primary Completion Date

June 18, 2024

Study Completion Date

June 18, 2024

Conditions
Type 2 Diabetes Mellitus
Interventions
COMBINATION_PRODUCT

Connected Solution with H2S app which connects with blood glucose meter (BGM)

Combination of the Insultrate titration module software, the H2S app for participants, and the H2S platform for healthcare professionals

Trial Locations (14)

100

National Taiwan University Hospital - Investigational site number 1580001, Taipei

106

Cathay General Hospital - Investigational Site Number: 1580006, Taipei

220

Far-Eastern Memorial Hospital - Investigational Site Number: 1580004, New Taipei City

235

Shuang Ho Hospital - Investigational Site Number: 1580012, New Taipei City

500

Changhua Christian Hospital - Investigational Site Number: 1580016, Changhua

710

Chi-Mai Medical Center - Investigational Site Number: 1580002, Tainan City

33305

Chang-Gung Memorial Hospital Linkou Branch - Investigational Site Number: 1580005, New Taipei City

40201

Chung-Shan University Hospital - Investigational Site Number: 1580003, Taichung

112201

Taipei Veterans General Hospital - Investigational Site Number: 1580015, Taipei

114202

Tri-Service General Hospital - Investigational Site Number: 1580014, Taipei

116079

Wan Fang Hospital - Investigational Site Number: 1580013, Taipei

435403

Tungs' Taichung Metroharbor Hospital - Investigational Site Number:1580011, Taichung

704302

National Cheng Kung University Hospital - Investigational Site Number: 1580008, Tainan City

813414

Kaohsiung Veterans General Hospital - Investigational site number 1580010, Kaohsiung City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05684341 - A Randomized Controlled Trial to Compare the Glycemic Control, With or Without the Connected Solution, of Adult Type 2 Diabetic Participants on Basal Insulin in Taiwan | Biotech Hunter | Biotech Hunter